Geron (GERN) Enterprise Value (2010 - 2026)
Geron's (GERN) quarterly Enterprise Value came in at -$245.4 million in Q1 2026, up 38.17% year-on-year from -$177.6 million in Q1 2025, and up 13.06% quarter-over-quarter from -$282.2 million in Q4 2025.
Geron (GERN) Enterprise Value (2010 - 2026) Analysis & Trends
Geron has disclosed Enterprise Value across 17 years of filings, most recently posting -$245.4 million for Q1 2026.
- Enterprise Value for Q1 2026 came in at -$245.4 million, up 38.17% year-over-year; the trailing twelve-month figure through Mar 2026 was -$245.4 million (up 38.17% YoY), and the FY2025 annual result was -$282.2 million, up 14.32% from the prior year.
- Enterprise Value came in at -$245.4 million for Q1 2026 at Geron, up from -$282.2 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$135.7 million in Q1 2022 to a low of -$396.9 million in Q1 2025.
- The 5-year median for Enterprise Value is -$282.2 million (2025), against an average of -$281.3 million.
- Across the five-year window, Enterprise Value plunged 180.56% in 2023 and soared 38.17% in 2026, its largest moves.
- Geron's Enterprise Value stood at -$172.7 million in 2022, then sank by 93.17% to -$333.7 million in 2023, then increased by 1.29% to -$329.4 million in 2024, then climbed by 14.32% to -$282.2 million in 2025, then grew by 13.06% to -$245.4 million in 2026.
- The last three Enterprise Value figures came in at -$245.4 million (Q1 2026), -$282.2 million (Q4 2025), and -$380.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -2.77 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | -18.44 Mn |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -584.73 Mn |
| 10 | Geron | 729,618.77 | 729,618.77 | - | -245.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -245.39 Mn |
| Dec 31, 2025 | -282.24 Mn |
| Sep 30, 2025 | -380.53 Mn |
| Jun 30, 2025 | -349.03 Mn |
| Mar 31, 2025 | -396.88 Mn |
| Dec 31, 2024 | -329.41 Mn |
| Sep 30, 2024 | -281.28 Mn |
| Jun 30, 2024 | -246.91 Mn |
| Mar 31, 2024 | -254.41 Mn |
| Dec 31, 2023 | -333.70 Mn |
| Sep 30, 2023 | -283.35 Mn |
| Jun 30, 2023 | -371.38 Mn |
| Mar 31, 2023 | -380.74 Mn |
| Dec 31, 2022 | -172.75 Mn |
| Sep 30, 2022 | -194.79 Mn |
| Jun 30, 2022 | -143.59 Mn |
| Mar 31, 2022 | -135.71 Mn |
| Dec 31, 2021 | -183.72 Mn |
| Sep 30, 2021 | -147.45 Mn |
| Jun 30, 2021 | -198.24 Mn |